Thus, our study indicates that, in intubated critically ill patients, the accuracy of PTX3 levels in BAL fluid for diagnosing pneumonia might be superior to other current biomarkers and clinical markers, especially when nonbacterial and/or non-VAP cases are suspected. The gene discussed is PTX3; the disease is susceptibility to pneumonia measurement.